FDA HAS UPDATED THE EMERGENCY USE AUTHORIZATION – Click to Learn More

 

FOR MORE INFORMATION ON THROMBOSIS WITH THROMBOCYTOPENIA SYNDROME (TTS) - Click Here

The Janssen COVID-19 Vaccine

Johnson & Johnson's Janssen COVID-19 Vaccine: Authorized for Emergency Use

The Janssen COVID-19 Vaccine has not been approved or licensed by the U.S. Food and Drug Administration (FDA), but has been authorized by FDA through an Emergency Use Authorization (EUA) for active immunization to prevent Coronavirus Disease 2019 (COVID-19) in individuals 18 years of age and older for whom other FDA-authorized or approved COVID-19 vaccines are not accessible or clinically appropriate, and in individuals 18 years of age and older who elect to receive the Janssen COVID-19 Vaccine because they would otherwise not receive a COVID-19 vaccine. The Janssen COVID-19 Vaccine can cause blood clots with low levels of platelets (blood cells that help your body stop bleeding), which may be fatal.

Want to Learn More About Johnson & Johnson's Janssen COVID‑19 Vaccine and Relevant Booster Dose Information?

DISCOVER MORE
Discover more about Janssen COVID-19 Vaccine
Find out about getting janssen COVID-19 vaccine

Can I Get Johnson & Johnson's Janssen COVID‑19 Vaccine?

FIND OUT

Looking for Information
About COVID‑19?

Learn More
Learn more about COVID-19
Discover more about COVID-19 resoures

Need COVID‑19 Resources?

DISCOVER MORE

COVID-19=coronavirus disease 2019.